Skip to main content
. 2011 May 20;11:4. doi: 10.1186/1472-6904-11-4

Table 2.

Incidence of adverse events

Spironolactone users Spironolactone non-users
Hyperkalemia 408/12,344
(3.3%)
955/69,674
(1.4%)*

Breast complications in men 158/6,368
(2.5%)
380/32,764
(1.2%)*

Breast hypertrophy in men (gynecomastia) 117/6,368
(1.8%)
233/32,764
(0.7%)*

* p < 0.001 (Pearson's chi square test)